-
Huabo Kaisheng Dapoxetine Hydrochloride Tablets Obtained First Domestic Approval
Time of Update: 2020-04-21
Pharmaceutical Network April 21, April 17, the new three-plate pharmaceutical company Guangdong Tynekang Pharmaceuticals issued a notice that the subsidiary Shandong Huapu Kaisheng recently received
-
Rotating evaporator shopping tips: do not understand these, advise you not to rush to hand
Time of Update: 2020-04-16
Pharmaceutical Network Technical Article: Rotating evaporators are mainly used for concentration, crystallization, drying, separation and solvent recovery in the pharmaceutical, chemical and biopharm
-
China's new crown vaccine enters Phase II clinical trial for 84-year-olds
Time of Update: 2020-04-15
Medicine Network April 15 by the Military Academy of Sciences Institute of Biological Engineering Research Chen Wei team developed adenovirus vector recombinant new coronavirus vaccine, on the 12th t
-
International Group of Experts Issues Declaration on Cooperation in Vaccine Development, Accelerates Vaccine Development
Time of Update: 2020-04-14
Medicine Network April 14 - A group of more than 120 scientists, doctors, funders and producers from around the world issued an open declaration on the 13th, pledging to work together under the coord
-
China's first peripheral drug elution stent approved for listing
Time of Update: 2020-04-10
Medicine Network April 10, April 9, the State Drug Administration announced that it approved the priority products produced by Cook Ireland Limited , "drug excitatora peripheral vascular stents" regi
-
Aosaikang declared 3.1 antifungal carbaryl acetate API
Time of Update: 2020-04-03
According to the CFDA website on March 27, the API of kapofungin acetate, a class 3.1 new drug, which was applied for production by arcmecon, was accepted At present, only the original drug kapofungin
-
Two projects in Inner Mongolia were supported by the national science and technology major project of "major new drug creation"
Time of Update: 2020-04-03
Two projects of Inner Mongolia Autonomous Region were supported by the national science and technology major project of "major new drug creation", among which "research and development of new and high
-
Biopharmaceutical - imitation success is also a high-tech NB industry!
Time of Update: 2020-04-03
What is the biological similar drug? First, introduce the difference between the original research drug (also called patent drug) and the generic drug Patent medicine is a kind of medicine produced by
-
Xiansheng pharmaceutical and Shiguibao to develop new rheumatoid arthritis drug orencia
Time of Update: 2020-04-03
On July 2, Xiansheng pharmaceutical and BMS announced at their long-term R & D strategic cooperation ceremony that they would jointly develop in China the subcutaneous injection type of orencia, a bio
-
18 first imitations with the most fierce domestic competition in the first half of 2014
Time of Update: 2020-04-03
Rheumatoid arthritis of tuofatibu Postoperative pain of Jiangsu Xiansheng, Zhengda Tianqing, aosaikang, Sichuan Kelun, Tianjin hankang, Shiyao group, kefeiping, Guangzhou egger, China Resources SECCO
-
On site inspection of low molecular weight heparin calcium API of Dongcheng pharmaceutical
Time of Update: 2020-04-03
According to the information on January 26 on the website of the State Food and Drug Administration (CFDA), Dongcheng pharmaceutical's key product, low molecular weight heparin calcium API, has entere
-
Fangsheng pharmaceutical continued to increase the promotion of new drug research and development in 2015
Time of Update: 2020-04-03
"New drug research and development has always been our core advantage At present, our new anti-cancer drugs have reached the stage of expert review It is estimated that in three or five months, there
-
Changchun hi tech subsidiary's Baike biological herpes zoster live attenuated vaccine obtained clinical approval
Time of Update: 2020-04-03
Changchun hi tech announced on July 6 that the biological product "live attenuated herpes zoster vaccine" declared by Baike biology, the holding subsidiary of the company, has been approved for clinic
-
Phase III study of hpatinib in the treatment of advanced gastric cancer
Time of Update: 2020-04-03
According to Hengrui pharmaceutical company, apatinib's phase III research on the treatment of advanced gastric cancer will make an oral report at the annual meeting of the American Society of Clinica
-
Key technology of modern preparation of traditional Chinese medicine won the first prize of Tianjin Science and Technology Progress Award
Time of Update: 2020-04-03
To develop a new drug in the field of traditional Chinese medicine, it is often necessary to understand the chemical composition, identify the efficacy, human metabolism research and other aspects of
-
Kangyuan pharmaceutical's exclusive variety of Cistanche total glycoside capsule in the treatment of vascular dementia has obtained new drug certificate
Time of Update: 2020-04-03
According to the information on the website of the State Food and Drug Administration (CFDA) on July 1, the review status of the exclusive product of Kangyuan pharmaceutical, Cistanche total glycoside
-
Zaiding Pharmaceutical Co., Ltd. and South Korea and the United States jointly develop EGFR targeted lung cancer drug hm61713
Time of Update: 2020-04-03
It is reported that hm61713 is the third generation irreversible tyrosine kinase inhibitor targeting EGFR mutation, targeting at T790M mutant tumors At the 2015 ASCO annual meeting, South Korea and th
-
Rip biological porcine circovirus vaccine is expected to be available in the second quarter
Time of Update: 2020-04-03
The head of rip biology told reporters yesterday that porcine circovirus type 2 (PCV2) is one of the three major viral infectious diseases emerging in recent years, which has brought serious economic
-
Kunming Pharmaceutical Group 3.2 ferrous fumarate tablets for iron deficiency anemia
Time of Update: 2020-04-03
According to the public information released by the State Food and Drug Administration on April 29, the 3.2-class iron deficiency anemia drug of Kunming Pharmaceutical Co., Ltd., ferrous folic acid fu
-
Wuzhou Pharmaceutical Co., Ltd. and dema Co., Ltd. are still in the phase II clinical stage of FDA
Time of Update: 2020-04-03
At the annual performance presentation meeting on May 8, Zhongheng group said that Wuzhou pharmaceutical, a subsidiary of Zhongheng group, cooperated with dema company to carry out the FDA clinical ce
